Klein MB - Search Results

1

Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.

Potter M, Odueyungbo A, Yang H, Saeed S, Klein MB; Canadian Co-infection Cohort Study Investigators. Potter M, et al. Among authors: klein mb. AIDS. 2010 Jul 31;24(12):1857-65. doi: 10.1097/QAD.0b013e32833adbb5. AIDS. 2010. PMID: 20479633

2

Didanosine, interferon-alfa and ribavirin: a highly synergistic combination with potential activity against HIV-1 and hepatitis C virus.

Klein MB, Campeol N, Lalonde RG, Brenner B, Wainberg MA. Klein MB, et al. AIDS. 2003 May 2;17(7):1001-8. doi: 10.1097/01.aids.0000060357.78202.25. AIDS. 2003. PMID: 12700449

3

The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy.

Klein MB, Lalonde RG, Suissa S. Klein MB, et al. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):365-72. doi: 10.1097/00126334-200307010-00011. J Acquir Immune Defic Syndr. 2003. PMID: 12843748

4

The impact of initial highly active antiretroviral therapy on future treatment sequences in HIV infection.

Klein MB, Willemot P, Murphy T, Lalonde RG. Klein MB, et al. AIDS. 2004 Sep 24;18(14):1895-904. doi: 10.1097/00002030-200409240-00005. AIDS. 2004. PMID: 15353975

5

Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy.

Willemot P, Klein MB. Willemot P, et al. Among authors: klein mb. Expert Rev Anti Infect Ther. 2004 Aug;2(4):521-32. doi: 10.1586/14787210.2.4.521. Expert Rev Anti Infect Ther. 2004. PMID: 15482218 Review.

6

The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001.

Beck EJ, Mandalia S, Gaudreault M, Brewer C, Zowall H, Gilmore N, Klein MB, Lalonde R, Piché A, Hankins CA. Beck EJ, et al. Among authors: klein mb. AIDS. 2004 Dec 3;18(18):2411-8. AIDS. 2004. PMID: 15622317

7

Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons.

Boulassel MR, Morales R, Murphy T, Lalonde RG, Klein MB. Boulassel MR, et al. Among authors: klein mb. J Med Virol. 2006 Sep;78(9):1158-63. doi: 10.1002/jmv.20676. J Med Virol. 2006. PMID: 16847953 Clinical Trial.

8

Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker.

Al-Mohri H, Murphy T, Lu Y, Lalonde RG, Klein MB. Al-Mohri H, et al. Among authors: klein mb. J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):463-9. doi: 10.1097/QAI.0b013e318030ff8e. J Acquir Immune Defic Syndr. 2007. PMID: 17211282

9

Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts.

Moodie EE, Pant Pai N, Klein MB. Moodie EE, et al. Among authors: klein mb. PLoS One. 2009;4(2):e4517. doi: 10.1371/journal.pone.0004517. Epub 2009 Feb 18. PLoS One. 2009. PMID: 19223976 Free PMC article.

10

Impact of HIV-1 viral subtype on CD4+ T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare.

Keller M, Lu Y, Lalonde RG, Klein MB. Keller M, et al. Among authors: klein mb. AIDS. 2009 Mar 27;23(6):731-7. doi: 10.1097/QAD.0b013e328326f77f. AIDS. 2009. PMID: 19279446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters